Bcma-Based Stratification And Therapy For Multiple Myeloma Patients

Patent No. EP2699259 (titled "Bcma-Based Stratification And Therapy For Multiple Myeloma Patients") was filed by Boehringer Ingelheim on Apr 20, 2012. The application was issued on Jul 27, 2016.

Patent Family

Statuses, jurisdictions and citation links are shared on request.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
HEIDELBERG PHARMA	Apr 27, 2017	VIRNEKAS
MATHYS & SQUIRE	Apr 27, 2017	WILDING
MILLER DAVID JAMES GRIFFIN PHILIPPA JANE	Apr 27, 2017	MILLER
JANSSEN BIOTECH	Apr 25, 2017	GOODFELLOW

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

May 31, 2018
Communication to the parties concerning the termination of the opposition proceedings (opponent)
May 31, 2018
Communication to the parties concerning the termination of the opposition proceedings (opponent)
May 31, 2018
Communication to the parties concerning the termination of the opposition proceedings (opponent)
May 31, 2018
Communication to the parties concerning the termination of the opposition proceedings (opponent)
May 31, 2018
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
May 28, 2018
Termination of the opposition proceedings with revocation of patent
Mar 13, 2018
Advice of delivery
Feb 26, 2018
Advice of delivery
Feb 26, 2018
Advice of delivery
Feb 26, 2018
Advice of delivery
Feb 20, 2018
(Electronic) Receipt
Feb 20, 2018
(Electronic) Receipt
Feb 20, 2018
Advice of delivery
Feb 20, 2018
Advice of delivery
Feb 20, 2018
Advice of delivery
Feb 20, 2018
Letter accompanying subsequently filed items
Feb 20, 2018
Letter accompanying subsequently filed items
Feb 19, 2018
Advice of delivery
Feb 19, 2018
Advice of delivery
Feb 16, 2018
Acknowledgement of a document
Feb 16, 2018
Acknowledgement of a document
Feb 16, 2018
Acknowledgement of a document
Feb 16, 2018
Acknowledgement of a document
Feb 16, 2018
Acknowledgement of a document
Feb 16, 2018
Decision of the Opposition Division and instruction
Feb 16, 2018
Decision revoking the European patent
Feb 16, 2018
Grounds for the decision (Annex) - opposition
Feb 16, 2018
Internal form - Opposition/addressees
Feb 16, 2018
Scanned annex to a communication - opposition procedure
Jun 6, 2017
Communication of a notice of opposition and request to file observations
Jun 6, 2017
Notice of further oppositions to opponent(s)
Jun 6, 2017
Notice of further oppositions to opponent(s)
Jun 6, 2017
Notice of further oppositions to opponent(s)
Jun 6, 2017
Notice of further oppositions to opponent(s)
May 15, 2017
Communication of a notice of opposition - first information to patent proprietor
May 9, 2017
Communication of a notice of opposition - first information to patent proprietor
Apr 27, 2017
(Electronic) Receipt
Apr 27, 2017
(Electronic) Receipt
Apr 27, 2017
Any annexes (other than citation) to an opposition letter
Apr 27, 2017
Letter regarding the opposition procedure (no time limit)
Apr 27, 2017
Letter regarding the opposition procedure (no time limit)
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Non-patent literature cited during the opposition procedure
Apr 27, 2017
Notice of opposition
Apr 27, 2017
Notice of opposition
Apr 27, 2017
Notice of opposition
Apr 27, 2017
Notice of opposition
Apr 27, 2017
Notice of opposition
Apr 27, 2017
Notice of opposition
Apr 27, 2017
Notice of opposition
Apr 27, 2017
Patent document cited during the opposition procedure
Apr 27, 2017
Patent document cited during the opposition procedure
Apr 27, 2017
Patent document cited during the opposition procedure
Apr 27, 2017
Patent document cited during the opposition procedure
Apr 27, 2017
Patent document cited during the opposition procedure
Apr 27, 2017
Payment of fees and costs
Apr 25, 2017
(Electronic) Receipt
Apr 25, 2017
Any annexes (other than citation) to an opposition letter
Apr 25, 2017
Non-patent literature cited during the opposition procedure
Apr 25, 2017
Non-patent literature cited during the opposition procedure
Apr 25, 2017
Non-patent literature cited during the opposition procedure
Apr 25, 2017
Non-patent literature cited during the opposition procedure
Apr 25, 2017
Non-patent literature cited during the opposition procedure
Apr 25, 2017
Non-patent literature cited during the opposition procedure
Apr 25, 2017
Non-patent literature cited during the opposition procedure
Apr 25, 2017
Non-patent literature cited during the opposition procedure
Apr 25, 2017
Non-patent literature cited during the opposition procedure
Apr 25, 2017
Non-patent literature cited during the opposition procedure
Apr 25, 2017
Non-patent literature cited during the opposition procedure
Apr 25, 2017
Non-patent literature cited during the opposition procedure
Apr 25, 2017
Non-patent literature cited during the opposition procedure
Apr 25, 2017
Notice of opposition
Apr 25, 2017
Notice of opposition
Apr 25, 2017
Patent document cited during the opposition procedure
Apr 25, 2017
Patent document cited during the opposition procedure
Jul 28, 2016
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jun 30, 2016
Decision to grant a European patent
Jun 13, 2016
(Electronic) Receipt
Jun 13, 2016
Filing of the translations of the claims
Jun 13, 2016
French translation of claims
Jun 13, 2016
German translation of the claims
Jun 13, 2016
Letter accompanying subsequently filed items
Jun 3, 2016
Notice drawing attention to the payment of the renewal fee and additional fee
Feb 1, 2016
Bibliographic data of the European patent application
Feb 1, 2016
Communication about intention to grant a European patent
Feb 1, 2016
Intention to grant (signatures)
Feb 1, 2016
Intention to grant (signatures)
Feb 1, 2016
Text intended for grant (clean copy)
Feb 1, 2016
Text intended for grant (sequence listing)
Feb 1, 2016
Text intended for grant (version for approval)
Jan 15, 2016
Confirmation of revocation of automatic debit order
Jan 13, 2016
Annex to the communication
Jan 13, 2016
Consultation by telephone/in person
Jan 13, 2016
Result of consultation by telephone/in person
Jan 12, 2016
Letter relating to the automatic debiting procedure
Jan 7, 2015
(Electronic) Receipt
Jan 7, 2015
Amended claims with annotations
Jan 7, 2015
Claims
Jan 7, 2015
Letter accompanying subsequently filed items
Jan 7, 2015
Reply to communication from the Examining Division
Sep 11, 2014
Annex to the communication
Sep 11, 2014
Communication from the Examining Division
Sep 1, 2014
Examination started
Jul 15, 2014
CDS Clean up - amended data concerning the representative for the applicant
May 26, 2014
Amended claims filed after receipt of (European) search report
May 26, 2014
Amendments received before examination
May 26, 2014
Letter accompanying subsequently filed items
Feb 21, 2014
Priority document (electronically transmitted)
Jan 29, 2014
Notification on forthcoming publication of bibliographic data
Dec 13, 2013
Communication concerning correction of deficiencies in written opinion/amendment of application/payment of claims fee
Dec 7, 2013
Priority search results copy provided by EPO
Dec 6, 2013
Communication to designated inventor
Dec 6, 2013
Communication to designated inventor
Nov 21, 2013
(Electronic) Receipt
Nov 21, 2013
Request for entry into the European phase
Nov 5, 2013
Copy of the international preliminary report on patentability
Aug 30, 2013
Information on entry into European phase
Nov 14, 2012
Priority document (electronically transmitted)
Oct 26, 2012
Copy of the international search report
Oct 26, 2012
Published international application - A1
Jun 22, 2012
Written opinion of the ISA, boxes No. I to VIII
Jun 22, 2012
Written opinion of the ISA, cover sheet
Jun 22, 2012
Written opinion of the ISA, supplemental box
Apr 20, 2012
(Electronic) Receipt
Apr 20, 2012
Abstract
Apr 20, 2012
Claims
Apr 20, 2012
Description
Apr 20, 2012
Drawings
Apr 20, 2012
Submission concerning representation

EP2699259

BOEHRINGER INGELHEIM

Application Number: EP12714730A
Filing Date: Apr 20, 2012
Status: Revoked; Jun 1, 2018
Publication Date: Jul 27, 2016
External Links: Slate, Register , Google Patents

IP Verse

Bcma-Based Stratification And Therapy For Multiple Myeloma Patients

Patent Summary

Patent Family

Patent Oppositions (4)

Dossier Documents

EP2699259